FEB 07, 2017 10:00 AM PST

WEBINAR: Beyond 100,000: Insights & Lessons from Large-Scale Sequencing in the Cloud

Sponsored by: DNAnexus
Speaker
  • Executive Director, Head of Genome Informatics, Regeneron Genetics Center
    Biography
      Dr. Jeffrey G. Reid, Ph.D., is Executive Director, Head of Genome Informatics at the Regeneron Genetics Center, a large-scale sequencing initiative marrying exome sequence data with patient EMRs to improve patient outcomes and provide a blueprint for a future where genomics plays a central role in all aspects of drug development as well as the everyday practice of medicine. Dr. Reid focuses on the integration of EMR and sequence data in large data sets to provide insights into basic biology and improve patient outcomes. Before moving to Regeneron, Dr. Reid served for over six years as the leader of the next-generation sequencing informatics group at the Human Genome Sequencing Center at the Baylor College of Medicine. Dr. Reid has been involved in all aspects of high-throughput DNA sequence analysis applications, from the on-instrument primary analysis to algorithm development for data handling, variant calling, annotation, and all analysis steps in between. Using his experience in early big data analysis research from his work in relativistic heavy-ion collision physics computation in graduate school, Dr. Reid is a pioneer in the field of cloud-based genomics. Dr. Reid received his Ph.D. in physics from The University of Washington and his Bachelor's degree from Harvey Mudd College.

    Abstract

    DATE: February 7, 2017
    TIME: 10:00am PT, 1:00pm ET

    In this webinar, Jeffrey G. Reid, PhD, Executive Director and Head of Genome Informatics at Regeneron Pharmaceuticals, will share how the Regeneron Genetics Center (RGC) has built one of the world’s most comprehensive genetics databases, pairing the sequenced exomes and de-identified electronic health records of more than 100,000 people to date, with plans to ultimately sequence more than 250,000 people.  

    Described as the largest clinical sequencing undertaking in North America, the RGC collaborates with 30 institutions to marry healthcare provider and academic expertise with translational follow up, in essence making data actionable. By analyzing genomic and phenotypic data and making associations between genes and disease, the goal of the RGC collaboration is to make discoveries that inform and speed the drug development process. Ultimately, the hope is to improve patient healthcare outcomes through the development of new therapeutics for a broad range of serious medical conditions. 

    Regeneron selected DNAnexus to provide the cloud-based bioinformatics platform that enables various RCG research partnerships through the sharing and management of large-scale sequencing data and genomic tools. On February 7th, hear from one of the leading genetic experts discuss RGC’s integrated approach across genetic trait architectures and phenotypes, the underlying cloud infrastructure that makes possible the multi-institution collaboration, and key lessons learned from RGC’s pioneering genomic sequencing study. 

    Learning Objectives:

    • Why Regeneron is investing in human genetics
    • How the marriage between genotypes and phenotypes supports target drug discovery & validation

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    FEB 07, 2017 10:00 AM PST

    WEBINAR: Beyond 100,000: Insights & Lessons from Large-Scale Sequencing in the Cloud

    Sponsored by: DNAnexus

    Specialty

    Genetics

    Bioinformatics

    Molecular Biology

    Cancer Research

    Molecular Diagnostics

    Genomics

    Biotechnology

    Cancer Diagnostics

    Clinical Diagnostics

    Dna Sequencing

    Laboratory Testing

    Clinical Research

    Immunology

    Microbiology

    Oncology

    Geography

    North America73%

    Europe12%

    Asia7%

    South America3%

    Africa2%

    Registration Source

    Website Visitors100%

    Job Title

    Executive21%

    Facility/Department Manager12%

    Research Scientist11%

    Scientist9%

    Student9%

    Educator/Faculty8%

    Medical Doctor/Specialist7%

    Lab Management5%

    Medical Laboratory Technician4%

    Post Doc4%

    Consultant4%

    Engineer3%

    Biologist3%

    Marketing/Sales2%

    Organization

    Academic Institution6%

    Biotech Company5%

    Clinical Laboratory4%

    Life Science Company4%

    Hospital4%

    Research Institute3%

    Consultant3%

    Pharmaceutical Company2%

    Medical School2%

    Ambulatory Care1%

    Medical Center1%

    Contract Research Organization (Cro)1%

    Medical Device Company1%

    Government1%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more